Carlos Prudencio

Dr. Carlos Prudencio

Multipurpoe Laboratory, Instituto Butantan, São Paulo, Brazil
orcid
Research Scientist

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AMAndrew D. Moura
Andrew D. Moura
HCHernan Hermes Monteiro da Costa
Hernan Hermes Monteiro da Costa
VCVictor A. Correa
Victor A. Correa
ALAna K. de S. Lima
Ana K. de S. Lima
JLJosé A. L. Lindoso
José A. L. Lindoso
CPCarlos R. Prudencio
Carlos R. Prudencio
SARS-CoV-2 is considered a global emergency, resulting in an exacerbated crisis in the health public in the world. Although there are advances in vaccine development, it is still limited for many countries. On the other hand, an immunological response that mediates protective immunity or indicates that predict disease outcome in SARS-CoV-2 infection remains undefined. This work aimed to assess the antibody levels, avidity, and subclasses of IgG to RBD protein, in symptomatic patients with severe and mild forms of COVID-19 in Brazil using an adapted in-house RBD-IgG ELISA. The RBD IgG-ELISA showed 100% of specificity and 94.3% of sensibility on detecting antibodies in the sera of hospitalized patients. Patients who presented severe COVID-19 had higher anti-RBD IgG levels compared to patients with mild disease. Additionally, most patients analyzed displayed low antibody avidity, with 64.4% of the samples of patients who recovered from the disease and 84.6% of those who died in this avidity range. Our data also reveals an increase of IgG1 and IgG3 levels since the 8th day after symptoms onset, while IgG4 levels maintained less detectable during the study period. Surprisingly, patients who died during 8–14 and 15–21 days also showed higher anti-RBD IgG4 levels in comparison with the recovered (P < 0.05), suggesting that some life-threatening patients can elicit IgG4 to RBD antibody response in the first weeks of symptoms onset. Our findings constitute the effort to clarify IgG antibodies' kinetics, avidity, and subclasses against SARS-CoV-2 RBD in symptomatic patients with COVID-19 in Brazil, highlighting the importance of IgG antibody avidity in association with IgG4 detection as tool laboratory in the follow-up of hospitalized patients with more significant potential for life-threatening.

1 July 2010 in Vaccine
Verified
Journal Article
Closed access
CPCarlos R. Prudencio
Carlos R. Prudencio
JLJosé Pérez de la Lastra
José Pérez de la Lastra
MCMario Canales
Mario Canales
MVMargarita Villar
Margarita Villar
Jose De La FuenteJose De La Fuente
Jose De La Fuente

1 June 2015 in Ticks and Tick-borne Diseases
Verified
Journal Article
Closed access
MOMaria Ogrzewalska
Maria Ogrzewalska
ILIvan Literák
Ivan Literák
MCMiroslav Capek
Miroslav Capek
OSOldřich Sychra
Oldřich Sychra
VCVíctor Álvarez Calderón
Víctor Álvarez Calderón
MLMarcelo Bahia Labruna
Marcelo Bahia Labruna

1 August 2010 in Veterinary Parasitology
Verified
Journal Article
Closed access
CPCarlos R. Prudencio
Carlos R. Prudencio
AMAndrea O.M. Marra
Andrea O.M. Marra
RCRone Cardoso
Rone Cardoso
LGLuiz Ricardo Goulart
Luiz Ricardo Goulart

1 January 2010 in Immunobiology
Verified
Journal Article
Closed access
JJJair Pereira da Cunha Junior
Jair Pereira da Cunha Junior
DSDeise A.O. Silva
Deise A.O. Silva
NSNeide M. Silva
Neide M. Silva
MSMaria A. Souza
Maria A. Souza
GSGuilherme R.L. Souza
Guilherme R.L. Souza
JMJose Roberto Mineo
Jose Roberto Mineo

25 October 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
HIHimanshu
Himanshu
CPCarlos R. Prudencio
Carlos R. Prudencio
Antonio Charlys Da-CostaAntonio Charlys Da-Costa
Antonio Charlys Da-Costa
Elcio LealElcio Leal
Elcio Leal
CCChung-Ming Chang
Chung-Ming Chang
Ramendra Pati PandeyRamendra Pati Pandey
Ramendra Pati Pandey
Since the discovery of antibiotics in the 20th century, they have been used to fight against infections. The overuse of antibiotics in the wider environment has resulted in the emergence of multidrug-resistant bacteria. In developing countries such as China and developed countries such as the USA, there is evidence of the high pervasiveness of antibiotic-resistant infections. However, the studies on the spread of antibiotic-resistant microorganisms that inform about the consequences are limited. The aim of our study was to analyze and compare antimicrobial resistance (AMR) identified in published research papers from that found in different food sources, which were published between 2012 and December 2021, covering most retail food items. Out of 132 research papers identified, 26 papers have met our strict criteria and are included in the qualitative and quantitative analysis. The selected papers led to 13,018 food samples, out of which 5000 samples were contaminated, including 2276 and 2724 samples from China and the USA, respectively. Meat, aquatic products, milk, and eggs show high to medium potential for AMR exposure to Gram-positive bacteria such as Staphylococcus, Enterococci, etc. and Gram-negative foodborne pathogens such as Campylobacter, Salmonella, Vibrio, etc. Most of the food samples show antibiotic resistance to β-lactams, tetracycline, quinolones, and aminoglycosides. Retail food products such as meat, sea food, and some other food products, as well as AMR genetics and technically important bacteria, are proposed to be better merged with mitigation strategies and systematic One Health AMR surveillance to minimize the knowledge gaps and facilitate comprehensive AMR risk computation for the consumers.